Table 1.
Before routine IOUS (1991-1997) | Routine IOUS (1998-2006) | P | |
Patient number (n) | 368 | 276 | |
Male/Female | 140/228 | 107/169 | 0.85 |
Age (yr) | 53.3 ± 13.9 | 57.1 ± 13.6 | 0.004 |
Operative indications, n (%) | 0.73 | ||
Cholecystolithiasis | 296 (80.4) | 228 (82.6) | |
Cholecystocholedocholithiasis | 39 (10.6) | 23 (10.5) | |
Choledocholithiasis | 7 (1.9) | 4 (1.4) | |
Gallbladder polyp | 22 (6.0) | 11 (4.0) | |
Others1 | 4 (1.1) | 4 (1.4) | |
Symptomatic gallstones, n (%) | 284 (77.2) | 220 (79.7) | 0.44 |
Acute cholecystitis/cholangitis, n (%) | 42 (11.4) | 32 (11.6) | 0.94 |
Bile duct diameter2 (mm) | 8.9 ± 4.2 | 8.4 ± 3.6 | 0.12 |
Other benign processes including chronic cholecystitis and adenomyomatosis, which need whole biopsy of the gallbladder for suspected malignancy.
Maximal dimension of the extrahepatic bile duct was measured by drip infusion cholangiography (51%), endoscopic retrograde cholangiography (35%), percutaneous transhepatic cholangiography (4%), magnetic resonance cholangiography (2%), and/or extracorporeal ultrasonography (8%).